Bacteromic sp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-03-03
Share capital
38,105,000.00 PLN
Activity description

Bacteromic is a diagnostic system that focuses on determining antibiotic susceptibility using microfluidic technology. It addresses the global issue of antibiotic resistance by providing phenotypic assessments of antibiotic effectiveness. The system aims to combat multidrug resistance, which poses significant challenges in modern medicine.

Registered address
ul. Ogrodowa 58, 00-876 Warszawa, Poland
Phone
Social media
Electronic delivery address
AE:PL-81905-19932-BVJUH-15

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 57 days early. All were audited by a statutory auditor.

  • 202527/04/2026
  • 202403/07/2025
  • 202307/06/2024
  • 202203/04/2023
  • 202104/07/2022
  • 202007/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 43%
City · Warszawa34,620 / 56,772
Top 61%
Voivodeship · Mazowieckie48,096 / 76,953
Top 63%
Country · Poland190,097 / 297,266
Top 64%

Results vs industry

Revenue
This companyUSD 112.73kMedianUSD 73.13kAverageUSD 3.24m
Net profit
This companyUSD -4.85mMedianUSD 68.58AverageUSD 88.16k
Operating costs
This companyUSD 4.90mMedianUSD 75.83kAverageUSD 3.05m
Assets
This companyUSD 14.89mMedianUSD 120.25kAverageUSD 3.91m

Offer

  • Diagnostic system for antimicrobial susceptibility testing
  • Antimicrobial susceptibility testing
  • Detection of bacterial resistance mechanisms

Websites

The site is available in: Polish and English.

  • bacteromic.comStrona główna – BACTEROMIC
    WordPress 3.7ElementorGoogle Tag ManagerRank MathWPMLCloudflareLiteSpeed

Trademarks

The company holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2021.

MarkNumberClassesStatusProtected until
Bacteromic (word)Z.5722291, 5, 9, 10Protected Jul 19, 2034
BACTEROMIC Z.5239841, 5, 9, 10Protected Feb 2, 2031
MarkProtected until
Bacteromic (word)Jul 19, 2034
BACTEROMIC Feb 2, 2031

Job offers

The company has its own careers page: bacteromic.com/kariera.

Authorized Representatives

Bernd Eberhardt – Attorney-in-fact (joint)
Piotr Garstecki age 51 – President of the Management Board
Marcin Izydorzak age 52 – Management Board Member
Szymon Michał Ruta age 51 – Management Board Member

Manner of representation

In the case of a one-person management board, the company shall be represented by the sole member of the management board acting independently. In the case of a multi-member management board, the company shall be represented by two members of the management board acting jointly, or one member of the management board jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
762,100$10,293,084.82100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-03-30.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

7 public aid cases recorded, with a total value of $680,510.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

European Funds

4 projects recorded: 3 from FE lists ($1,130,513) and 1 Commission grant (FTS) ($2,156,328).

ProjectEU co-financing
Intelligence for precision therapies against antimicrobial resistance: the first diagnostic panel that probes all the clinically relevant antibiotics at once
$2.2M
Obtaining international patent protection for the invention "Metoda szybkiego wykrywania wzrostu bakterii"
$53,523
Obtaining international patent protection for the inventions "Chip mikroprzepływowy" and "Segment inkubacyjny"
$98,564

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Seamaty Polska sp. z o.o.
Tecom Analytical Systems-Poland sp. z o.o.
Oasis Diagnostics S.A.
Brain Optics sp. z o.o.
GMT Id S.A.
V-Lab sp. z o.o.

Change history

DateEvent
2026-10-07Share capital increase
2026-05-15Share capital increase
2025-10-28Share capital increase
2025-06-02Share capital increase
2024-11-25Share capital increase

FAQ

Last updated: 2026-11-12